Travere Therapeutics (NasdaqGM:TVTX) 2025 Conference November 18, 2025 10:00 AM ET Company ParticipantsPeter Heerma - Chief Commercial OfficerEric Dube - CEOConference Call ParticipantsMaury Raycroft - AnalystMaury RaycroftHi everyone, my name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome the Travere management team. We've got Eric Dube, the CEO, and Peter Heerma, the Chief Commercial Officer. Thanks so much for joining us today. We're ...